Page last updated: 2024-08-21

2-piperidone and Carcinoma, Squamous Cell of Head and Neck

2-piperidone has been researched along with Carcinoma, Squamous Cell of Head and Neck in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chen, CW; Chen, YL; Hsieh, MJ; Hsieh, YH; Ju, PC; Lin, CW; Su, CW; Yang, SF1
da Fonseca, ACC; de Sousa, DP; Machado, TQ; Perez-Castillo, Y; Robbs, BK; Silva, RHN; Tejera, E1
Arrendale, RF; Chen, ZG; Culver, D; Evers, TJ; Fu, H; Howard, RB; Khuri, FR; Moore, TW; Morii, N; Reddy, P; Shin, DM; Shoji, M; Sica, G; Snyder, JP; Sun, A; Zhang, H; Zhu, S1

Other Studies

3 other study(ies) available for 2-piperidone and Carcinoma, Squamous Cell of Head and Neck

ArticleYear
Curcumin analog HO-3867 triggers apoptotic pathways through activating JNK1/2 signalling in human oral squamous cell carcinoma cells.
    Journal of cellular and molecular medicine, 2022, Volume: 26, Issue:8

    Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Curcumin; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Piperidones; Squamous Cell Carcinoma of Head and Neck

2022
Molecular Modeling and In Vitro Evaluation of Piplartine Analogs against Oral Squamous Cell Carcinoma.
    Molecules (Basel, Switzerland), 2023, Feb-09, Volume: 28, Issue:4

    Topics: Cell Line, Tumor; Humans; Mouth Neoplasms; Piperidones; Quality of Life; Squamous Cell Carcinoma of Head and Neck

2023
Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
    Current cancer drug targets, 2014, Volume: 14, Issue:4

    Topics: Animals; Antineoplastic Agents; Biological Availability; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Curcumin; Female; Half-Life; Head and Neck Neoplasms; Humans; I-kappa B Kinase; Mice, Inbred ICR; Mice, Nude; Neoplasm Proteins; Phosphorylation; Piperidones; Protein Processing, Post-Translational; Pyridines; Random Allocation; Specific Pathogen-Free Organisms; Squamous Cell Carcinoma of Head and Neck; Transcription Factor RelA; Tumor Burden; Xenograft Model Antitumor Assays

2014